Stem cell bill is back

Two senior senators reintroduced a Senate bill yesterday (Feb. 26) that would lift the US ban on federal funding for stem cell research. Senators Tom Harkin (left), ArlenSpecter and Orrin HatchImage: A.C. Glenn/UPI/Newscom/APThe bipartisan measure by Senators Tom Harkin (D-Iowa) and Arlen Specter (R-Penn.) would permit research on human embryonic stem cell lines regardless of the date the tissue was obtained and allow new cell lines to be derived from human embryos left over from fertility trea

Written byElie Dolgin
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Two senior senators reintroduced a Senate bill yesterday (Feb. 26) that would lift the US ban on federal funding for stem cell research.
Senators Tom Harkin (left), Arlen
Specter and Orrin Hatch

Image: A.C. Glenn/UPI/Newscom/AP
The bipartisan measure by Senators Tom Harkin (D-Iowa) and Arlen Specter (R-Penn.) would permit research on human embryonic stem cell lines regardless of the date the tissue was obtained and allow new cell lines to be derived from human embryos left over from fertility treatments. The same bill passed both houses of Congress in 2007, but was vetoed by then-President Bush. On the campaign trail, President Obama promised to reverse Bush's policy, and one of Obama's key science advisors, Harold Varmus, linkurl:said last month;http://www.the-scientist.com/blog/display/55391/ that the President would issue an executive order in "the near future." But White House spokesperson Robert Gibbs has also suggested that Obama would rather wait and work together with Congress on the measure, according to__ linkurl:Reuters.;http://uk.reuters.com/article/scienceNews/idUKTRE51P7ZQ20090226 __"This legislation is necessary to codify this important policy change so that it does not ping-pong back and forth with each successive President," said Specter in a linkurl:statement.;http://specter.senate.gov/public/index.cfm?FuseAction=NewsRoom.NewsReleases&ContentRecord_id=b4814200-e50d-320d-4d9b-97fe10555231&Region_id=&Issue_id= "We have to make sure that the freedom to pursue this research is also protected by Federal law, not merely by an executive order that can be reversed during a future administration," said Harkin in a linkurl:statement.;http://specter.senate.gov/public/index.cfm?FuseAction=NewsRoom.NewsReleases&ContentRecord_id=b4814200-e50d-320d-4d9b-97fe10555231&Region_id=&Issue_id= Three other senior senators -- Edward Kennedy (D-Mass.), Dianne Feinstein (D-Calif.), and Orrin Hatch (R-Utah) -- cosponsored the legislation.
**__Related stories:__***linkurl:Bush's stem cell ban to end?;http://www.the-scientist.com/blog/display/55391/
[30th January 2009]*linkurl:New U.S. congress, new stem cell bills;http://www.the-scientist.com/news/display/39808/
[4th January 2007]*linkurl:Stem cell supporters upset by Bush veto;http://www.the-scientist.com/news/display/23995/
[20th July 2006]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies